Immunologically oriented therapy (immunotherapy) has arguably proved to be the most effective method for treating advanced melanoma, the prototypical chemotherapy-resistant solid tumor. The efficacy and benefit of immunotherapy for other tumors, including those that are at least partly responsive to chemotherapy, is less well established. Breast cancer, one of the most common of the solid tumors in humans, is partially responsive to traditional chemotherapy. We believe that breast cancer patients, like melanoma patients, will benefit from the application of immunotherapy techniques. Here we review the different forms of laser immunotherapy (LIT), a key type of immunologically oriented therapy, discuss its use in melanoma and in breast cancer, and discuss its potentially pivotal role in the immunotherapy armamentarium.
Mark Naylor, Xiaosong Li, Tomas Hode, Lu Alleruzzo, Joseph Raker, Siu Kit Lam, Feifan Zhou, and Wei Chen, "Laser immunotherapy for advanced solid tumors," Proc. SPIE 10065, Biophotonics and Immune Responses XII, 1006509 (Presented at SPIE BiOS: January 30, 2017; Published: 7 March 2017); https://doi.org/10.1117/12.2254746.
Conference Presentations are recordings of oral presentations given at SPIE conferences and published as part of the conference proceedings. They include the speaker's narration along with a video recording of the presentation slides and animations. Many conference presentations also include full-text papers. Search and browse our growing collection of more than 12,000 conference presentations, including many plenary and keynote presentations.